Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Hemolytic Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01597401
What this trial is testing

A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Baxalta now part of Shire 19
Not applicableStudy completedNCT01569971
What this trial is testing

Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 55
Large-scale testing (Phase 3)Study completedNCT02174900
What this trial is testing

Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 70
Not applicableStudy completedNCT02069236
What this trial is testing

Comparing G6PD Tests Using Capillary Blood Versus Venous Blood

Who this might be right for
Glucose-6 Phosphate Dehydrogenase Deficiency
PATH 150
Testing effectiveness (Phase 2)Looking for participantsNCT06198712
What this trial is testing

Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Forma Therapeutics, Inc. 95
Large-scale testing (Phase 3)Ended earlyNCT03040765
What this trial is testing

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis

Who this might be right for
Thalassemia Majors (Beta-Thalassemia Major)Osteoporosis
Hamad Medical Corporation 17
Not applicableStudy completedNCT00895154
What this trial is testing

A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study

Who this might be right for
Sickle Cell Disease
Washington University School of Medicine 21
Not applicableLooking for participantsNCT07206095
What this trial is testing

Integrative Diagnosis for SCD and Other RADs

Who this might be right for
Sickle Cell DiseaseThalassaemiaCongenital Dyserythropoietic Anemia (CDA)+6 more
Hospital Universitari Vall d'Hebron Research Institute 200
Testing effectiveness (Phase 2)Ended earlyNCT02013375
What this trial is testing

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

Who this might be right for
Sickle Cell Disease
Damiano Rondelli, MD 2
Not applicableEnded earlyNCT03387033
What this trial is testing

Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell DiseaseVirtual RealityAnxiety+2 more
Duke University 20
Testing effectiveness (Phase 2)Study completedNCT01732718
What this trial is testing

Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Nephropathy
University of North Carolina, Chapel Hill 13
Testing effectiveness (Phase 2)WithdrawnNCT04938635
What this trial is testing

Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia

Who this might be right for
Beta-Thalassemia
Vifor (International) Inc.
Not applicableUnknownNCT06019208
What this trial is testing

GenoMed4ALL: Improving SCD Classification and Prognosis by AI

Who this might be right for
Sickle Cell Disorders
Hospital Universitari Vall d'Hebron Research Institute 1,000
Not applicableNot Yet RecruitingNCT07802210
What this trial is testing

Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia in Children
Aula Ibrahim abd alrazak 120
Testing effectiveness (Phase 2)Study completedNCT01389024
What this trial is testing

Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseStroke
Johns Hopkins University 28
Large-scale testing (Phase 3)Study completedNCT02675790
What this trial is testing

Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa

Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaStroke
Vanderbilt University Medical Center 120
Not applicableUnknownNCT06058260
What this trial is testing

Assessment of Cognitive Function and Quality of Life in Thalassemic Children at Sohag University Hospital

Who this might be right for
Thalassemia
Sohag University 100
Not applicableStudy completedNCT04973280
What this trial is testing

Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)

Who this might be right for
Myelodysplastic SyndromesBeta-thalassemia
Celgene 187
Testing effectiveness (Phase 2)Ended earlyNCT01601340
What this trial is testing

Effects of HQK-1001 in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaSickle Cell Disorders+2 more
HemaQuest Pharmaceuticals Inc. 77
Testing effectiveness (Phase 2)Study completedNCT03263559
What this trial is testing

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

Who this might be right for
Sickle Cell Disease
Medical College of Wisconsin 95
Next Page